Search clinical trials for: Lenalidomide-Dexamethasone-DLI

Total 5199 results

M.D. Anderson Cancer Center
Ziopharm Oncology

Completed

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Lymphoma | Leukemia

United States
Stichting Hemato-Oncologie voor Volwassenen Nederland

Not yet recruiting

FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM) (HOVON174MM)

Multiple Myeloma
Attaya Suvannasankha
Janssen Scientific Affairs, LLC; Indiana Institute for Medical Research

Withdrawn

Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy

Multiple Myeloma

United States
IRCCS Policlinico S. Matteo
Celgene Corporation

Completed

Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis

Amyloidosis

Italy
Scarless Laboratories, Inc.

Recruiting

Dose Regimen Study of SLI-F06 in Healthy Volunteers

Scar | Wound Healing

United States
M.D. Anderson Cancer Center
Direct Therapeutics

Completed

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Glioma | Brain Neoplasms

United States
University Hospital Muenster

Unknown

DTI in Children With Multiple Sclerosis

Clinically Isolated Syndrome, CNS Demyelinating | Multiple Sclerosis - Relapsing Remitting

Germany
Ache Laboratorios Farmaceuticos S.A.

Completed

Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis (DaVinci)

Tinea

Brazil
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia

Myelodysplastic Syndrome

United States
ClinAmygate

Recruiting

Anosmia and / or Ageusia and Early Corticosteroid Use

Covid19 | Anosmia

Egypt
University of Chicago

Active, not recruiting

Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma

Multiple Myeloma

United States, Poland
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Biologics,...

Active, not recruiting

Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone

Solitary Osseous Plasmacytoma

United States
Weill Medical College of Cornell University
Celgene Corporation

Completed

Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma

Multiple Myeloma

United States
Cancer Trials Ireland
Sanofi; Dana-Farber Cancer Institute

Recruiting

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma (Isa-RVD)

Multiple Myeloma

Denmark, Ireland
Nantes University Hospital

Completed

VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome (VIDAZA-DLI)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

France
Mayo Clinic
National Cancer Institute (NCI)

Completed

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Grupo Español de Linfomas y Transplante Autólogo...
Celgene Corporation; Dynamic Science S.L.; Thermo Fisher Scientific, Inc

Completed

Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

Spain
Zhao Wang

Unknown

Sintilimab and Lenalidomide as a Treatment for CAEBV

CAEBV

China
Celgene Corporation
ICON Clinical Research

Completed

Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality

Myelodysplastic Syndromes

Germany, Israel, United Kingdom, Spain, Belgium, Italy, France, Netherlands, Sweden
Vanderbilt University Medical Center

Withdrawn

Cervical Interlaminar Versus Transforaminal Epidural Steroid Injection

Cervical Radiculopathy
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaborators

Active, not recruiting

Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
Dame Products, Inc.
Citruslabs

Completed

An Exploratory Investigation to Identify if Dame Product's "DLM" Works to Improve Sexual Desire and Mood in Females

Sexual Desire Disorder

United States
Wake Forest University Health Sciences

Completed

EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery

Thoracic Injuries

United States
Masimo Corporation

Completed

Accuracy of Noninvasive Pulse Oximeter Sensor (LNCS DBI)

Healthy

United States
Masimo Corporation

Completed

Accuracy of Noninvasive Pulse Oximeter Sensor (Rainbow DCI)

Healthy

United States
King's College Hospital NHS Trust

Unknown

Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy (PRO-DLI)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute

United Kingdom
Cancer Trials Ireland

Completed

Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

Ireland
Cairo University

Not yet recruiting

Assessment of Oral Health Knowledge, Attitude and Behaviour of Dental Students in Cairo University

Oral Health Knowledge, Attitude and Behaviour of Dental Students
Qianqian Qu

Not yet recruiting

DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene

Malignant Tumor of the Ovary | XRCC2 Gene Mutation
Lille Catholic University

Recruiting

Diffusion Tensor (DTI) for the Assessement of Therapeutic Evolution of Patients With Acute Lumbar Radiculalgia (DiTi-Aïe)

Magnetic Resonance Imaging | Lumbar Radiculopathy | Diffusion Tensor Imaging

France
Sanofi

Completed

Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation

Plasma Cell Myeloma

France, Germany, Italy, Spain
Topcon Medical Systems, Inc.

Withdrawn

OCT Image Quality Performance Evaluation

Healthy Eyes

United States
Qure Healthcare, LLC
Aegis Sciences Corporation

Completed

DDI Effectiveness and Clinical Awareness (DECART)

Drug-Drug Interactions

United States
Masimo Corporation

Completed

Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (RD DCI)

Healthy

United States
Sun Yat-sen University

Recruiting

VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma

Myeloma | Newly Diagnosed | High Risk

China
BioNTech SE

Not yet recruiting

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

Triple Negative Breast Cancer | Locally Advanced Breast Cancer
American College of Radiology Imaging Network
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Unknown

DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer (ACRIN6702)

Breast Cancer | BIRADS 3 | BIRADS 4 | BIRADS 5

United States
Cedars-Sinai Medical Center
Amgen

Active, not recruiting

Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL

B-ALL | B-Cell Acute Lymphoblastic Leukaemia | ALL, Adult

United States
Obstetrix Medical Group

Completed

A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome (ACS)

Preterm Delivery

United States
Intergroupe Francophone du Myelome

Completed

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

Myeloma

France
The First Hospital of Jilin University

Unknown

Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma

Multiple Myeloma in Relapse

China
Hackensack Meridian Health
Merck Sharp & Dohme LLC

Completed

Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens (RZD)

Multiple Myeloma

United States
Affiliated Hospital to Academy of Military Medical...

Unknown

Linked Color Imaging/Magnifying Blue Laser Imaging vs. White Light for Adenomas and Serrated Lesions in Proximal Colon

Colon Cancer

China
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers

Healthy Volunteers

Poland
Boston VA Research Institute, Inc.
Celgene Corporation; Edward Hines Jr. VA Hospital; Michael E. DeBakey VA Medical... and other collaborators

Completed

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

Multiple Myeloma

United States
University of Rochester
National Cancer Institute (NCI); National Institute on Aging (NIA)

Recruiting

Study of a Behavioral Intervention for Older Advanced Cancer Patients and Their Caregivers (urochester)

Cancer, Advanced | Cognitive Impairment, Mild

United States
Weill Medical College of Cornell University

Recruiting

pCHIP: Prostate Cancer Health Impact Program

Prostate Cancer

United States
University Hospital, Montpellier

Terminated

Ciliation and Mucus Rheology Parameters Determined Via Air-liquid-interface Cell Cultures in Non-smoking, Smoking, COPD and Asthmatic Patients (RhéMuc)

Smoking | Pulmonary Disease, Chronic Obstructive | Asthma

France
Topcon Medical Systems, Inc.

Completed

TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus

Healthy Eyes

United States
IHU Strasbourg

Completed

Assessment of MRI Tractography for Pelvic Floor Sphincter Analysis (TractoCA)

Inflammatory Bowel Disease | Neoplastic Pathology

France

Search clinical trials for: Lenalidomide-Dexamethasone-DLI

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations